{"DataElement":{"publicId":"4253971","version":"1","preferredName":"Genetic Mutation Abnormality Present Type","preferredDefinition":"A description of the genetic mutation abnormality(ies).","longName":"4253932v1.0:4253952v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"4253932","version":"1","preferredName":"Genetic Mutation Abnormality Present","preferredDefinition":"Having to do with information that is passed from parents to offspring through genes in sperm and egg cells._Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer._Being or existing in a specified place or at the specified time.","longName":"3234298v1.0:2233878v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"3234298","version":"1","preferredName":"Genetic Mutation Abnormality","preferredDefinition":"Having to do with information that is passed from parents to offspring through genes in sperm and egg cells; inherited.:A general term referring to single or multiple alterations in the genetic material of an organism that ranges from a single base change in a gene to the loss or addition of complete chromosomes. A mutation abnormality may be heritable or occur somatically.","longName":"C17938:C45576","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Genetic","conceptCode":"C17938","definition":"Having to do with information that is passed from parents to offspring through genes in sperm and egg cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Mutation Abnormality","conceptCode":"C45576","definition":"Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A2D95ED3-452B-1E47-E040-BB89AD436618","latestVersionIndicator":"Yes","beginDate":"2011-05-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-05-09","modifiedBy":"ONEDATA","dateModified":"2011-05-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2233878","version":"1","preferredName":"Present","preferredDefinition":"Being or existing in a specified place or at the specified time.","longName":"C25626","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Present","conceptCode":"C25626","definition":"Being or existing in a specified place or at the specified time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F970CDF6-F829-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"ONEDATA","dateModified":"2005-06-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F596CE79-5EB2-EC0E-E040-BB89AD430CD7","latestVersionIndicator":"Yes","beginDate":"2014-03-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-03-27","modifiedBy":"KUMMEROA","dateModified":"2016-07-28","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"4253952","version":"1","preferredName":"Genetic Mutation Abnormality Type","preferredDefinition":"Having to do with information that is passed from parents to offspring through genes in sperm and egg cells._Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer._Something distinguishable as an identifiable class based on common qualities.","longName":"4253952v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":"0","PermissibleValues":[{"value":"XLP2/XIAP (BIRC4)","valueDescription":"Baculoviral IAP Repeat-Containing Protein 4","ValueMeaning":{"publicId":"4293552","version":"1","preferredName":"Baculoviral IAP Repeat-Containing Protein 4","longName":"4293552","preferredDefinition":"Baculoviral IAP repeat-containing protein 4 (497 aa, ~57 kDa) is encoded by the human XIAP gene. This protein plays a role in both protein ubiquitination and the inhibition of apoptosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"E3 Ubiquitin-Protein Ligase XIAP","conceptCode":"C20947","definition":"Baculoviral IAP repeat-containing protein 4 (497 aa, ~57 kDa) is encoded by the human XIAP gene. This protein plays a role in both protein ubiquitination and the inhibition of apoptosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8CEEB06-8E17-E353-E040-BB89AD437F8B","latestVersionIndicator":"Yes","beginDate":"2014-05-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-05-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8CEEB06-8E30-E353-E040-BB89AD437F8B","beginDate":"2014-05-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-05-07","modifiedBy":"ONEDATA","dateModified":"2014-05-07","deletedIndicator":"No"},{"value":"XLP1/XLP (SH2D1A)","valueDescription":"SH2D1A wt Allele","ValueMeaning":{"publicId":"4293554","version":"1","preferredName":"SH2D1A wt Allele","longName":"4293554","preferredDefinition":"Human SH2D1A wild-type allele is located within Xq25-q26 and is approximately 27 kb in length. This allele, which encodes SH2 domain protein 1A, plays role in activation, proliferation and differentiation of B and T cells, induces production of IFN gamma, and changes the functional profile of subsets of T cells. Mutations in this gene are associated with X-linked lymphoproliferative (Duncan's) syndrome.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"SH2D1A wt Allele","conceptCode":"C75394","definition":"Human SH2D1A wild-type allele is located within Xq25-q26 and is approximately 27 kb in length. This allele, which encodes SH2 domain protein 1A, plays role in activation, proliferation and differentiation of B and T cells, induces production of IFN gamma, and changes the functional profile of subsets of T cells. Mutations in this gene are associated with X-linked lymphoproliferative syndrome 1 (Duncan Disease).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8CEEB06-8E3D-E353-E040-BB89AD437F8B","latestVersionIndicator":"Yes","beginDate":"2014-05-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-05-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8CEEB06-8E56-E353-E040-BB89AD437F8B","beginDate":"2014-05-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-05-07","modifiedBy":"ONEDATA","dateModified":"2014-05-07","deletedIndicator":"No"},{"value":"FHL 5/MUNC 18-2 (STXBP2)","valueDescription":"STXBP2 wt Allele","ValueMeaning":{"publicId":"4265071","version":"1","preferredName":"STXBP2 wt Allele","longName":"4265071","preferredDefinition":"Human STXBP2 wild-type allele is located within 19p13.3-p13.2 and is approximately 11 kb in length. This allele, which encodes syntaxin-binding protein 2, plays a role in  intracellular vesicle trafficking and vesicle fusion with membranes. Mutations in this gene are associated with familial hemophagocytic lymphohistiocytosis type 5.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"STXBP2 wt Allele","conceptCode":"C114623","definition":"Human STXBP2 wild-type allele is located within 19p13.3-p13.2 and is approximately 11 kb in length. This allele, which encodes syntaxin-binding protein 2, plays a role in intracellular vesicle trafficking and vesicle fusion with membranes. Mutations in this gene are associated with familial hemophagocytic lymphohistiocytosis type 5.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F688926C-5912-3D73-E040-BB89AD43288F","latestVersionIndicator":"Yes","beginDate":"2014-04-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-04-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F688926C-592B-3D73-E040-BB89AD43288F","beginDate":"2014-04-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-04-08","modifiedBy":"ONEDATA","dateModified":"2014-04-08","deletedIndicator":"No"},{"value":"FHL 4/Syntaxin 11 (STX11)","valueDescription":"STX11 wt Allele","ValueMeaning":{"publicId":"4265072","version":"1","preferredName":"STX11 wt Allele","longName":"4265072","preferredDefinition":"Human STX11 wild-type allele is located in the vicinity of 6q24.2 and is approximately 41 kb in length. This allele, which encodes syntaxin-11 protein, is involved in the regulation of protein transport between late endosomes and the trans-Golgi network. Mutations in this gene are associated with familial hemophagocytic lymphohistiocytosis type 4.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"STX11 wt Allele","conceptCode":"C114620","definition":"Human STX11 wild-type allele is located in the vicinity of 6q24.2 and is approximately 41 kb in length. This allele, which encodes syntaxin-11 protein, is involved in the regulation of protein transport between late endosomes and the trans-Golgi network. Mutations in this gene are associated with familial hemophagocytic lymphohistiocytosis type 4.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F688926C-5937-3D73-E040-BB89AD43288F","latestVersionIndicator":"Yes","beginDate":"2014-04-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-04-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F688926C-5950-3D73-E040-BB89AD43288F","beginDate":"2014-04-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-04-08","modifiedBy":"ONEDATA","dateModified":"2014-04-08","deletedIndicator":"No"},{"value":"FHL 3/MUNC 13-4 (UNC13D)","valueDescription":"UNC13D wt Allele","ValueMeaning":{"publicId":"4265073","version":"1","preferredName":"UNC13D wt Allele","longName":"4265073","preferredDefinition":"Human UNC13D wild-type allele is located in the vicinity of 17q25.1 and is approximately 17 kb in length. This allele, which encodes protein unc-13 homolog D protein, plays a role in the regulation of cytolytic granule secretion. Mutations in this gene are associated with familial hemophagocytic lymphohistiocytosis type 3.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"UNC13D wt Allele","conceptCode":"C114614","definition":"Human UNC13D wild-type allele is located in the vicinity of 17q25.1 and is approximately 17 kb in length. This allele, which encodes protein unc-13 homolog D protein, plays a role in the regulation of cytolytic granule secretion. Mutations in this gene are associated with familial hemophagocytic lymphohistiocytosis type 3.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F688926C-595C-3D73-E040-BB89AD43288F","latestVersionIndicator":"Yes","beginDate":"2014-04-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-04-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F688926C-5975-3D73-E040-BB89AD43288F","beginDate":"2014-04-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-04-08","modifiedBy":"ONEDATA","dateModified":"2014-04-08","deletedIndicator":"No"},{"value":"Other mutation","valueDescription":"Other Mutation Abnormality","ValueMeaning":{"publicId":"4253953","version":"1","preferredName":"Other Mutation Abnormality","longName":"4253953","preferredDefinition":"Different than the one(s) previously specified or mentioned.: Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Mutation Abnormality","conceptCode":"C45576","definition":"Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F596CE79-5EF4-EC0E-E040-BB89AD430CD7","latestVersionIndicator":"Yes","beginDate":"2014-03-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-03-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F596CE79-5F0D-EC0E-E040-BB89AD430CD7","beginDate":"2014-03-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-03-27","modifiedBy":"ONEDATA","dateModified":"2014-03-27","deletedIndicator":"No"},{"value":"IL2-inducible T-cell kinase (ITK)","valueDescription":"Tyrosine-Protein Kinase ITK/TSK","ValueMeaning":{"publicId":"4253955","version":"1","preferredName":"Tyrosine-Protein Kinase ITK/TSK","longName":"4253955","preferredDefinition":"Tyrosine-protein kinase ITK/TSK (620 aa, ~75 kDa) is encoded by the human ITK gene. This protein is involved in tyrosine phosphorylation and immunity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tyrosine-Protein Kinase ITK/TSK","conceptCode":"C29753","definition":"Tyrosine-protein kinase ITK/TSK (620 aa, ~75 kDa) is encoded by the human ITK gene. This protein is involved in tyrosine phosphorylation and immunity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F596CE79-5F1A-EC0E-E040-BB89AD430CD7","latestVersionIndicator":"Yes","beginDate":"2014-03-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-03-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F596CE79-5F33-EC0E-E040-BB89AD430CD7","beginDate":"2014-03-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-03-27","modifiedBy":"ONEDATA","dateModified":"2014-03-27","deletedIndicator":"No"},{"value":"FHL 2/Perforin deficiency (PRF1)","valueDescription":"Perforin-1","ValueMeaning":{"publicId":"4253957","version":"1","preferredName":"Perforin-1","longName":"4253957","preferredDefinition":"Perforin-1 (555 aa, ~61 kDa) is encoded by the human PRF1 gene. This protein is involved in the mediation of cytolysis of infected cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Perforin-1","conceptCode":"C97741","definition":"Perforin-1 (555 aa, ~61 kDa) is encoded by the human PRF1 gene. This protein is involved in the mediation of cytolysis of infected cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F596CE79-5F40-EC0E-E040-BB89AD430CD7","latestVersionIndicator":"Yes","beginDate":"2014-03-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-03-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F596CE79-5F59-EC0E-E040-BB89AD430CD7","beginDate":"2014-03-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-03-27","modifiedBy":"ONEDATA","dateModified":"2014-03-27","deletedIndicator":"No"},{"value":"HBA1 - HBA triplication (aaaanti3.7 / aa)","valueDescription":"Heterozygous Anti-3.7 HBA Rearrangement","ValueMeaning":{"publicId":"8041592","version":"1","preferredName":"Heterozygous Anti-3.7 HBA Rearrangement","longName":"8041592","preferredDefinition":"A complex cytogenetic abnormality where one copy of chromosome 16 has undergone chromosomal rearrangement in the vicinity of 16p13.3, which is the region containing the 2 genes that encode hemoglobin subunit alpha (HBA; alpha-globin), HBA1 and HBA2. This rearrangement results in amplification of a 3.7 kb fragment containing of one of the HBA genes (usually HBA2) and may lead to simultaneous deletion of the other HBA gene (usually HBA1).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Heterozygous Anti-3.7 HBA Rearrangement","conceptCode":"C185461","definition":"A complex cytogenetic abnormality where one copy of chromosome 16 has undergone chromosomal rearrangement in the vicinity of 16p13.3, which is the region containing the 2 genes that encode hemoglobin subunit alpha (HBA; alpha-globin), HBA1 and HBA2. This rearrangement results in amplification of a 3.7 kb fragment containing of one of the HBA genes (usually HBA2) and may lead to simultaneous deletion of the other HBA gene (usually HBA1).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D8151AA0-5487-270B-E053-4EBD850ADC8E","latestVersionIndicator":"Yes","beginDate":"2022-02-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-02-15","modifiedBy":"ONEDATA","dateModified":"2022-02-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8151AA0-54A0-270B-E053-4EBD850ADC8E","beginDate":"2022-02-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-02-15","modifiedBy":"ONEDATA","dateModified":"2022-02-15","deletedIndicator":"No"},{"value":"HBA1 - HBA deletion ( a3.7 / aa)","valueDescription":"Heterozygous HBA 3.7 kb Deletion","ValueMeaning":{"publicId":"8041593","version":"1","preferredName":"Heterozygous HBA 3.7 kb Deletion","longName":"8041593","preferredDefinition":"A cytogenetic abnormality where one copy of chromosome 16 has a 3.7 kb chromosomal deletion in the vicinity of 16p13.3, which is the region containing the 2 genes that encode hemoglobin subunit alpha (HBA; alpha-globin), HBA1 and HBA2. This chromosomal deletion either deletes one of these two genes (usually HBA1) or results in a single copy of a functional, in-frame fusion of the two HBA genes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Heterozygous HBA 3.7 kb Deletion","conceptCode":"C185460","definition":"A cytogenetic abnormality where one copy of chromosome 16 has a 3.7 kb chromosomal deletion in the vicinity of 16p13.3, which is the region containing the 2 genes that encode hemoglobin subunit alpha (HBA; alpha-globin), HBA1 and HBA2. This chromosomal deletion either deletes one of these two genes (usually HBA1) or results in a single copy of a functional, in-frame fusion of the two HBA genes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D8151AA0-54AC-270B-E053-4EBD850ADC8E","latestVersionIndicator":"Yes","beginDate":"2022-02-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-02-15","modifiedBy":"ONEDATA","dateModified":"2022-02-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8151AA0-54C5-270B-E053-4EBD850ADC8E","beginDate":"2022-02-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-02-15","modifiedBy":"ONEDATA","dateModified":"2022-02-15","deletedIndicator":"No"},{"value":"KLF1 - c.115 A>C","valueDescription":"KLF1 NM_006563.5:c.115A>C","ValueMeaning":{"publicId":"8041594","version":"1","preferredName":"KLF1 NM_006563.5:c.115A>C","longName":"8041594","preferredDefinition":"A nucleotide substitution at position 115 of the coding sequence of the KLF1 gene where adenine has been mutated to cytosine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"KLF1 NM_006563.5:c.115A>C","conceptCode":"C185456","definition":"A nucleotide substitution at position 115 of the coding sequence of the KLF1 gene where adenine has been mutated to cytosine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D8151AA0-54D1-270B-E053-4EBD850ADC8E","latestVersionIndicator":"Yes","beginDate":"2022-02-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-02-15","modifiedBy":"ONEDATA","dateModified":"2022-02-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8151AA0-54EA-270B-E053-4EBD850ADC8E","beginDate":"2022-02-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-02-15","modifiedBy":"ONEDATA","dateModified":"2022-02-15","deletedIndicator":"No"},{"value":"KLF1 - c.892 G>C","valueDescription":"KLF1 NM_006563.5:c.892G>C","ValueMeaning":{"publicId":"8041595","version":"1","preferredName":"KLF1 NM_006563.5:c.892G>C","longName":"8041595","preferredDefinition":"A nucleotide substitution at position 892 of the coding sequence of the KLF1 gene where guanine has been mutated to cytosine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"KLF1 NM_006563.5:c.892G>C","conceptCode":"C185455","definition":"A nucleotide substitution at position 892 of the coding sequence of the KLF1 gene where guanine has been mutated to cytosine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D8151AA0-54F6-270B-E053-4EBD850ADC8E","latestVersionIndicator":"Yes","beginDate":"2022-02-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-02-15","modifiedBy":"ONEDATA","dateModified":"2022-02-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8151AA0-550F-270B-E053-4EBD850ADC8E","beginDate":"2022-02-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-02-15","modifiedBy":"ONEDATA","dateModified":"2022-02-15","deletedIndicator":"No"},{"value":"HMIP - rs66650371 wt>3bp deletion","valueDescription":"NC_000006.12:g.135097497_135097499del","ValueMeaning":{"publicId":"8041596","version":"1","preferredName":"NC_000006.12:g.135097497_135097499del","longName":"8041596","preferredDefinition":"An intergenic deletion of a three nucleotide sequence, cytosine-thymine-adenine, in the region between the HBS1L and MYB genes on chromosome 6 at genomic positions 135097497 through 135097499.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"NC_000006.12:g.135097497_135097499del","conceptCode":"C185446","definition":"An intergenic deletion of a three nucleotide sequence, cytosine-thymine-adenine, in the region between the HBS1L and MYB genes on chromosome 6 at genomic positions 135097497 through 135097499.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D8151AA0-551B-270B-E053-4EBD850ADC8E","latestVersionIndicator":"Yes","beginDate":"2022-02-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-02-15","modifiedBy":"ONEDATA","dateModified":"2022-02-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8151AA0-5534-270B-E053-4EBD850ADC8E","beginDate":"2022-02-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-02-15","modifiedBy":"ONEDATA","dateModified":"2022-02-15","deletedIndicator":"No"},{"value":"BCL11A - rs10189857 A>G","valueDescription":"BCL11A NC_000002.12:g.60486100A>G","ValueMeaning":{"publicId":"8041597","version":"1","preferredName":"BCL11A NC_000002.12:g.60486100A>G","longName":"8041597","preferredDefinition":"A nucleotide substitution on chromosome 2 at genomic position 60486100 located within intron 2 of the BCL11A gene where adenine has been mutated to guanine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"BCL11A NC_000002.12:g.60486100A>G","conceptCode":"C185442","definition":"A nucleotide substitution on chromosome 2 at genomic position 60486100 located within intron 2 of the BCL11A gene where adenine has been mutated to guanine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D8151AA0-5540-270B-E053-4EBD850ADC8E","latestVersionIndicator":"Yes","beginDate":"2022-02-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-02-15","modifiedBy":"ONEDATA","dateModified":"2022-02-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8151AA0-5559-270B-E053-4EBD850ADC8E","beginDate":"2022-02-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-02-15","modifiedBy":"ONEDATA","dateModified":"2022-02-15","deletedIndicator":"No"},{"value":"BCL11A - rs1427407 G>T","valueDescription":"BCL11A NC_000002.12:g.60490908=","ValueMeaning":{"publicId":"8041598","version":"1","preferredName":"BCL11A NC_000002.12:g.60490908=","longName":"8041598","preferredDefinition":"A nucleotide substitution on chromosome 2 at genomic position 60490908 located within intron 2 of the BCL11A gene where thymine is present instead of guanine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"BCL11A NC_000002.12:g.60490908=","conceptCode":"C185441","definition":"A nucleotide substitution on chromosome 2 at genomic position 60490908 located within intron 2 of the BCL11A gene where thymine is present instead of guanine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D8151AA0-5565-270B-E053-4EBD850ADC8E","latestVersionIndicator":"Yes","beginDate":"2022-02-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-02-15","modifiedBy":"ONEDATA","dateModified":"2022-02-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8151AA0-557E-270B-E053-4EBD850ADC8E","beginDate":"2022-02-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-02-15","modifiedBy":"ONEDATA","dateModified":"2022-02-15","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"5682953","version":"1","preferredName":"Unknown","longName":"5682953","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"498B4645-0FC6-0802-E053-F662850AB305","latestVersionIndicator":"Yes","beginDate":"2017-02-27","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-02-27","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D796DAE7-18B6-17C2-E053-4EBD850AE182","beginDate":"2022-02-09","endDate":null,"createdBy":"MALUMK","dateCreated":"2022-02-09","modifiedBy":"ONEDATA","dateModified":"2022-02-09","deletedIndicator":"No"},{"value":"Not done","valueDescription":"Not Done","ValueMeaning":{"publicId":"3104692","version":"1","preferredName":"Not Done","longName":"3104692v1.00","preferredDefinition":"Indicates a task, process or examination that has either not been initiated or not been completed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Done","conceptCode":"C49484","definition":"Indicates a task, process or examination that has either not been initiated or not been completed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"88084310-6796-6259-E040-BB89AD4311C3","latestVersionIndicator":"Yes","beginDate":"2010-06-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-02","modifiedBy":"RAGUNATHANU","dateModified":"2022-05-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D796DAE7-18C0-17C2-E053-4EBD850AE182","beginDate":"2022-02-09","endDate":null,"createdBy":"MALUMK","dateCreated":"2022-02-09","modifiedBy":"ONEDATA","dateModified":"2022-02-09","deletedIndicator":"No"},{"value":"HBG2 (XmnI) - rs7482144 C>T","valueDescription":"HBG2 NM_000184.2:c.-211C>T","ValueMeaning":{"publicId":"8041599","version":"1","preferredName":"HBG2 NM_000184.2:c.-211C>T","longName":"8041599","preferredDefinition":"A nucleotide substitution at position -211 in the upstream promoter region of the HBG2 gene where cytosine has been mutated to thymine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"HBG2 NM_000184.2:c.-211C>T","conceptCode":"C185439","definition":"A nucleotide substitution at position -211 in the upstream promoter region of the HBG2 gene where cytosine has been mutated to thymine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D8151AA0-558A-270B-E053-4EBD850ADC8E","latestVersionIndicator":"Yes","beginDate":"2022-02-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-02-15","modifiedBy":"ONEDATA","dateModified":"2022-02-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D8DCD3D5-194D-4FCE-E053-4EBD850A6EB6","beginDate":"2022-02-15","endDate":null,"createdBy":"MALUMK","dateCreated":"2022-02-25","modifiedBy":"ONEDATA","dateModified":"2022-02-25","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"4253951","version":"1","preferredName":"Genetic Mutation Abnormality Type","preferredDefinition":"Having to do with information that is passed from parents to offspring through genes in sperm and egg cells.:Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.:Something distinguishable as an identifiable class based on common qualities.","longName":"C17938:C45576:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Genetic","conceptCode":"C17938","definition":"Having to do with information that is passed from parents to offspring through genes in sperm and egg cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Mutation Abnormality","conceptCode":"C45576","definition":"Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F596CE79-5EC9-EC0E-E040-BB89AD430CD7","latestVersionIndicator":"Yes","beginDate":"2014-03-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-03-27","modifiedBy":"ONEDATA","dateModified":"2014-03-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F596CE79-5EDA-EC0E-E040-BB89AD430CD7","latestVersionIndicator":"Yes","beginDate":"2014-03-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-03-27","modifiedBy":"MALUMK","dateModified":"2022-02-25","changeDescription":". 2021-1-7 ak OK to release per WZ. PVs added for 2058r1. 02/09/2022 KMM 2022-2-15 AK aDDED pvS FOR km. Updated PV for 2058r1. 02/25/2022 KMM","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"What were the genetic mutatio","type":"Preferred Question Text","description":"What were the genetic mutation abnormalities present?","url":null,"context":"NHLBI"},{"name":"Specify genetic mutation(s) identified","type":"Alternate Question Text","description":"Specify genetic mutation(s) identified","url":null,"context":"NHLBI"},{"name":"Which genetic mutations were identified at diagnosis?","type":"Alternate Question Text","description":"Which genetic mutations were identified at diagnosis?","url":null,"context":"NHLBI"},{"name":"Which genetic mutations identified at diagnosis?","type":"Alternate Question Text","description":"Which genetic mutations identified at diagnosis?","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F596CE79-5F64-EC0E-E040-BB89AD430CD7","latestVersionIndicator":"Yes","beginDate":"2014-03-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-03-27","modifiedBy":"SORENSENS","dateModified":"2022-04-08","changeDescription":". 2021-1-7 ak OK to release per WZ. System generated def displayed as alt def. AK 10/26/14. AQT added for 2058r1. 02/15/2022 KMM","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}